Domínguez-Carral, Jana; Domínguez-Cobo, Ana-María; Balsells, Sol; Aguilar-Ros, Anna; Chang, Chu-Ting; Ludlam, William-G; Yang, Kathryn; Bernardi, Katerina; Chinigioli, Micaela; Salazar-Villacorta, Ainara; Di-Pisa, Veronica; Lamagrande-Casanova, Nuria; González-Alguacil, Elena; de-la-Casa-fages, Beatriz; Okumura, Akihisa; Rodríguez, Josefina; Agarwal, Ayush; Muñoz-Chesta, Daniela; Reynoso-Osnayo, Carolina; Lin, Amy; Tabarki, Brahim; Parvin, Jobaida; Gallo, Adolfo-Alberto; Forno, Andreia; Maass, Fabian; Blanco, Johnny-Montiel; Nasif, Salome; Jennions, Elizabeth; Ramon-Gómez, Jorge-Luis; Verhelst, Helene; Nieto-Barceló, Juan-José; Petrovic, Dunja-Cokolic; García-Ruiz, Luz-Victoria; van-Riesen, Christoph; Rego-Sousa, Paulo; Sánchez, María-del-Pilar-Massaro; Khan, Husnea-Ara; Hakami, Wejdan; Friedman, Jennifer; Espinoza-Quinteros, Iván; Troncoso, Mónica; Garg, Divyani; Pauni, Micaela; Kurahashi, Hirokazu; Miranda-Herrero, María-Concepción; Duat-Rodríguez, Anna; Soliani, Luca; Kurian, Manju-A; Schteinschnaider, Ángeles; Srivastava, Siddharth; Ebrahimi-Fakhari, Darius; Martemyanov, Kirill-A; Ortigoza-Escobar, Juan-Dario
(WILEY, 2026-07)
OBJECTIVE: Pathogenic variants in GNAO1 cause a spectrum of epilepsy, movement disorders, and developmental impairment. Clinical heterogeneity complicates prognosis and therapeutic development. We present the first ...